Calquence, INN-acalabrutinib
Acalabrutinib CYP3A‐mediated drug–drug interactions: Clinical evaluations and physiologically based pharmacokinetic modelling to inform dose adjustment strategy - Chen - 2022 - British Journal of Clinical Pharmacology - Wiley Online Library
Calquence, INN-acalabrutinib
AstraZeneca's Calquence approved in the EU for the treatment of most common type of leukaemia in adults » FINCHANNEL
AstraZeneca's BTK inhibitor Calquence gets EU approval to treat chronic lymphocytic leukaemia_Hong Kong Magicure Medical Center
Calquence (acalabrutinib) for the Treatment of Mantle Cell Lymphoma - Clinical Trials Arena
Brand Institute, Inc - Congratulations to AstraZeneca on the EMA approval of CALQUENCE! #BIBrands CALQUENCE is a prescription medicine used to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (
Calquence; INN-acalabrutinib
Frontiers | Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice
Evaluation and monitoring of medicines: highlights | EMA Annual Report 2020
AstraZeneca's BTK inhibitor Calquence gets EU approval to treat chronic lymphocytic leukaemia_Hong Kong Magicure Medical Center
Acalabrutinib - News, Articles etc. - European Pharmaceutical Review
Calquence (acalabrutinib) - News, Articles etc. - European Pharmaceutical Review
EMA Green Light for Avapritinib for GIST, Acalabrutinib for CLL - GDMedz
EC clears AstraZeneca's Calquence tablets for chronic lymphocytic leukaemia
Acalabrutinib - Wikipedia
CALQUENCE Plus Obinutuzumab Demonstrated Sustained Survival Benefit in 1st-line Chronic Lymphocytic Leukemia with 90% of Patients Surviving Five Years in ELEVATE-TN Trial | Business Wire
EMA finds possible link of AstraZeneca's COVID-19 vaccine with rare bl
Calquence; INN-acalabrutinib
Ascentage and AstraZeneca to conduct CLL/SLL therapy trial
NICE backs AZ's Calquence for new use in leukaemia | pharmaphorum
EMA recommends 11 new medicines for approval following July meeting
Calquence, INN-acalabrutinib
Acalabrutinib - Wikipedia
